Creese, Byron

Cognitive decline in Parkinson disease

Aarsland, D., Creese, B., Politis, M., Chaudhuri, K. R., ffytche, D. H., Weintraub, D., & Ballard, C. (2017) · Nature Reviews Neurology

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 1,027

The psychosis spectrum in Parkinson disease

ffytche, D. H., Creese, B., Politis, M., Chaudhuri, K. R., Weintraub, D., Ballard, C., & Aarsland, D. (2017) · Nature Reviews Neurology

Parkinson's Disease Mechanisms and TreatmentsHallucinations in medical conditions

Cited by 355

Psychosis in Alzheimer disease—mechanisms, genetics and therapeutic opportunities

Ismail, Z., Creese, B., Aarsland, D., Kales, H. C., Lyketsos, C. G., Sweet, R. A., & Ballard, C. (2022) · Nature Reviews Neurology

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 189

Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease

DeMichele-Sweet, M. A. A., Klei, L., Creese, B., Harwood, J. C., Weamer, E. A., McClain, L., Sims, R., Hernandez, I., Moreno-Grau, S., Tárraga, L., et al. (2021) · Molecular Psychiatry

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 64

Risky drinking and cognitive impairment in community residents aged 50 and over

Rao, R., Creese, B., Aarsland, D., Kalafatis, C., Khan, Z., Corbett, A., & Ballard, C. (2022) · Aging & Mental Health

Dementia and Cognitive Impairment ResearchSubstance Abuse Treatment and Outcomes

Cited by 14

Alzheimer’s disease genetics converges on microglial and neuronal dysregulation

Uffelmann, E., Wightman, D. P., Bahrami, S., Shadrin, A. A., Fominykh, V., Ojima, T., Jiang, C., Benner, C., Moreno, E., Campos, A. I., et al. (2026) · Nature

Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 0